Literature DB >> 11097120

Are cytokine patterns in aqueous humour useful in distinguishing corneal graft rejection from opacification due to herpetic stromal keratitis?

E B van Gelderen1, A Van der Lelij, H J Völker-Dieben, R van der Gaag, R Peek, W F Treffers.   

Abstract

PURPOSE: Intra-ocular cytokine profiles were determined to study the immunological mechanisms of corneal graft opacification due to rejection and/or herpetic stromal keratitis (HSK).
METHODS: Sera and aqueous humour (AH) were sampled shortly after the onset of corneal graft opacification, group I (n=18). In eyes with clear grafts, samples were taken 5 months after transplantation, group II (n=59). Samples of non-inflamed eyes, prior to cataract surgery, were used to determine baseline cytokine levels, group III (n=49). Total protein (TP) levels were measured with Bradford reagent and interleukin (IL)-6, IL-10, IL-4 and interferon (IFN)-gamma with ELISAs.
RESULTS: All patients who's corneal grafts showed clinical evidence of graft opacification due to rejection and/or HSK were sampled. In the AH-samples of group I, increased levels of TP were found in 60% (9/15), IL-6 in 79% (11/14), IL-10 in 39% (7/18) and IL-4 in none (0/12). IFN-gamma was detected in 19% (3/16), in the case of HSK only. In contrast, samples obtained from patients with clear grafts in group II showed increased levels of TP in 36% (20/55), IL-6 in 14% (8/57) and IL-10, IL-4 or IFN-gamma in none (n=58).
CONCLUSIONS: During corneal graft rejection and/or HSV-infection, increased levels of TP and IL-6 in AH confirmed anterior chamber inflammation with breakdown of the blood-aqueous barrier. Based on the data presented, cytokine patterns in the AH do not appear to distinguish corneal opacification due to graft rejection from that due to herpes keratitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11097120     DOI: 10.1023/a:1002734709753

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  23 in total

1.  Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection.

Authors:  D F Larkin; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1997-02       Impact factor: 4.330

2.  Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10.

Authors:  M Daheshia; N Kuklin; S Kanangat; E Manickan; B T Rouse
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

3.  Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid.

Authors:  E Aurelius; B Johansson; B Sköldenberg; A Staland; M Forsgren
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

4.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.

Authors:  Z S Zhao; F Granucci; L Yeh; P A Schaffer; H Cantor
Journal:  Science       Date:  1998-02-27       Impact factor: 47.728

5.  Cytokine mRNA expression during experimental corneal allograft rejection.

Authors:  P F Torres; A F De Vos; R van der Gaag; B Martins; A Kijlstra
Journal:  Exp Eye Res       Date:  1996-10       Impact factor: 3.467

6.  Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes.

Authors:  M Küchle; S A Vinores; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

7.  Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.

Authors:  T M Tumpey; V M Elner; S H Chen; J E Oakes; R N Lausch
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

8.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome.

Authors:  J H de Boer; L Luyendijk; A Rothova; G S Baarsma; P T de Jong; J G Bollemeijer; A J Rademakers; A Van der Lelij; M J Zaal; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1994-02-15       Impact factor: 5.258

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  4 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Total protein concentration and T-cell suppression activity of aqueous humour before and after penetrating keratoplasty.

Authors:  J-S Mo; P Maier; D Böhringer; H Reinshagen; R Sundmacher; T Reinhard
Journal:  Eye (Lond)       Date:  2011-11-18       Impact factor: 3.775

3.  A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.

Authors:  Fang Lei; Junfeng Zhang; Jinsong Zhang; Hao He; Ying Du; Peizeng Yang
Journal:  Mol Vis       Date:  2008-02-11       Impact factor: 2.367

4.  Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing.

Authors:  Zoltán Veréb; Szilárd Póliska; Réka Albert; Ole Kristoffer Olstad; Anita Boratkó; Csilla Csortos; Morten C Moe; Andrea Facskó; Goran Petrovski
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.